Market Research Blog – Page 2029 – New Product Development

Fiducial Markers Market Set to Skyrocket at 10.3% CAGR, Reaching US$408.3 Million by 2033 | FMI Research Report

The global market for fiducial markers is on track for a significant surge, fueled by growing demand across diverse industries. A recent market analysis by Future Market Insights reveals the industry’s current value at US$153.6 million in 2023. However, the future looks even brighter, with the market projected to experience a phenomenal Compound Annual Growth Rate (CAGR) of 10.3% over the next decade. This impressive growth trajectory translates to a projected market valuation of a staggering US$408.3 million by 2033

The meteoric rise of the Fiducial Markers Industry can be attributed to the expanding adoption of cutting-edge targeted radiotherapy techniques. These techniques, including image-guided radiotherapy, stereotactic radiosurgery, and intensity-modulated radiotherapy, rely on fiducial markers to precisely pinpoint tumors and deliver highly accurate radiation doses.

A game-changing factor in this surge is the integration of advanced navigation technologies such as the SPiN System. These innovations play a pivotal role in ensuring the precise placement of fiducial markers for surgical resection or radiation therapy. By empowering clinicians to pinpoint target sites with unparalleled accuracy, these technologies are driving down errors and revolutionizing treatment outcomes.

The compelling growth story of the Fiducial Markers Market reflects the dynamic landscape of healthcare, where precision and innovation converge to redefine patient care. As we move into the future, the synergy between radiotherapy advancements and cutting-edge navigation tools is set to elevate healthcare to unprecedented heights, offering patients a new ray of hope in their journey toward recovery.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-12825

Radiotherapy has become a widely accepted treatment modality for various types of cancers, including breast cancer stages 1 and 2. In fact, many patients receive radiotherapy in combination with breast-conserving surgery. Furthermore, government agencies and social organizations are actively funding research related to cancer and fiducial markers, contributing to the growth of the market.

Overall, the expanding application of fiducial markers in cancer treatment, coupled with advances in navigation technology and increased funding for research, will drive the growth of the global Fiducial Markers Industry in the upcoming years.

Modality-wise, the market constitutes ultrasound, CT/CBCT, X-ray, and MRI; out of which CT/CBCT holds a sizable market share and the trend is expected to remain the same even in the forecast period. This could be attributed to exposure to low doses, ease of integration with radiotherapy equipment that exists, and CBCT’s orthogonal imaging features are the factors basically driving the fiducial markers market.

Ultrasound modality would be the major contributor to the revenue due to its ability to provide real-time volumetric information along with organ tracking. It is widely used in treating liver, prostate, and breast cancer.

MRI modality does provide precise and reliable details regarding soft tissues while treating complex cases like orthotopic prostate tumors. MRI-based LINAC system is also being increasingly adopted.

Beacon FNF from Medtronic plc comes across as a pre-loaded gold fiducial marker system reducing the risk of complications commonly reported – like pneumothorax.

Future Market Insights has walked through these facts with insights in its latest market study entitled ‘Fiducial Markers Industry’. The team of analysts and consultants is there with its 360-degree view of primary, secondary, and tertiary modes of research.

“With various technological advancements being ushered for developing an advanced navigation system for appropriate product placement, the fiducial markers market is likely to grow on an altruistic note shortly”, says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Key Takeaways from the Fiducial Markers Market

North America holds the largest market share due to the US witnessing streamlined reimbursement policies along with public health programs. Plus, with advanced radiotherapy procedures and imaging modalities being increasingly adopted, the market is expected to flourish in the upcoming period.
Europe holds the second-largest market share. It has been observed that more than 3.2 Million contract cancer every single year. The geriatric population is more into colorectal and breast cancer. Plus, numerous fiducial markers are being approved by CE. On these grounds, BioXmark, in March 2020, did receive CE approval. It was devised by Nanovi A/S.
The Asia-Pacific is expected to witness growth at a rapid pace in the fiducial markers Industry in the forecast period. India and China are dominating the market. Along these lines, the government of China did relieve extra tax on 16 imported goods inclusive of medical LINAC systems.

Fiducial Markers Market Competitive Markers

Stratpharma AG, in the year 2019, did expand the agreement with US-based CIVCO for distributing the latter’s radiotherapy solutions at the global level.
IZI Medical Products, in 2019, acquired IBA’s RadioMed division, which produces VISICOIL implantable fiducial markers.
Nanovi A/S, in 2018, did secure US$ 2.23 Million from the existing investors for expanding business and introducing BioXmark in Europe.

What Does the Report Cover?

The research study is based on the product (polymer-based markers, metal-based markers, pure gold markers, and liquid-based markers), by modality (photon therapy, proton therapy, tomotherapy, and cyberknife), by disease site (head & neck, breast, lung, abdomen, prostate, kidney, and cervix or other gynecologic organs), and by end-user (hospitals, cancer research institutes, and radiotherapy centers).
With the increase in incidences of breast, prostate, and lung cancer with the growing adoption of radiotherapy for treating oncology, the global fiducial markers Industry is likely to witness persistence in the years to come.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/12825

Key Segments Covered in Fiducial Markers Market Research

Product:

Polymer Based Markers
Metal Based Markers
Pure Gold Markers
Liquid Based Markers

Modality:

Photon Therapy
Proton Therapy
Tomotherapy
Cyberknife

Disease Site:

Head & Neck
Breast
Lung
Abdomen
Prostate
Kidney
Cervix or other gynecologic organs

End User:

Hospitals
Cancer Research Institutes
Radiotherapy Centers

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vegan Asian Food Market Set to Achieve USD 30.8 Billion Valuation by 2033, Forecasts FMI

The vegan Asian food market is forecasted to be worth US$ 18,196.8 million in 2023 and to reach a worth of US$ 30,806.3 million by 2033. The demand for vegan Asian food is predicted to rise steadily with a CAGR of 6%.

As incomes rise in Asia, the disposable income of consumers has increased to spend on food. This trend is driven by economic growth and development in the region. With more disposable income, consumers can afford to purchase higher-valued food products, such as meat, dairy, and processed foods. This may drive demand for these types of products, as well as for premium and luxury food products.

Consumer preferences are changing in Asia, as people become more health conscious and look for foods that are low in sugar, salt, and fat. This trend is driven by the increasing awareness of the link between diet and health, and the growing prevalence of lifestyle-related diseases such as obesity and diabetes.

Download Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16603

Consumers are looking for food products that can help them maintain a healthy diet and prevent these diseases. Therefore, firms that produce healthy and natural food products, such as organic and whole foods, as well as functional foods that provide health benefits, may have a significant opportunity to capitalize on this trend.

Government support is also a driver of the vegan Asian food market. Governments in Asia are investing in the food industry to increase production and improve food security. This may lead to increased investment in the industry, the development of new technologies and products, and the creation of new jobs. Governments are also implementing policies and regulations to improve the safety and quality of food products. These policies may drive innovation and improvements in food safety and quality.

Innovation is also an opportunity in the vegan Asian meals market. Companies can develop new products and technologies to meet the changing needs of consumers. This can include the development of new packaging materials, new flavors, and new products that cater to specific consumer groups. This trend is driven by the need to differentiate products and stand out in a crowded market.

Consumers are becoming increasingly concerned about the safety and quality of food products. This trend is driven by the increasing awareness of food-borne illnesses and the negative impact of pesticides and chemical fertilizers on the environment. Consumers are looking for food products that are produced in compliance with food safety and quality standards.

Key Takeaways

The vegan Asian food market is growing at a fast pace due to increasing demand for plant-based products.
The market is driven by factors such as rising incomes, urbanization, and changing dietary habits.
Countries like China, India, and the United Kingdom are considered attractive markets for vegan Asian food.
The market is expected to see increased competition from both established food companies and startups.

Competitive Landscape

The competitive landscape in the vegan Asian food market is becoming increasingly crowded, with a growing number of companies entering the market. Traditional food companies are expanding their product offerings to include vegan options, while new startups are launching with a focus on vegan Asian food products.

In terms of startups, the vegan Asian food market is relatively new and the ecosystem is still developing. However, several startups are making a name for themselves in the market. These startups are focused on developing new and innovative vegan Asian food products, such as plant-based meat, dairy, and other protein products. Some examples include Impossible Foods, Beyond Meat, and Omnipork, which are known for their plant-based meat alternatives.

Large food companies are also starting to enter the market, such as Nestle, Unilever, and Tyson Foods, which are investing in plant-based protein research and development.

Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/16603

Key Segments

Alternative:

Fish Alternative
- Vegan Sashimi
- Vegan Unadon
- Vegan Daing
- Vegan Hitsumabushi
Crab Alternative
- Vegan Black Pepper Crab
- Vegan Gejang
- Vegan Chilli Crab
- Vegan Mitten Crab

Distribution Channel:

Direct Sales
Indirect Sales
- Specialty Stores
- Hypermarket/Supermarket
- Online Retail

Region:

North America
Latin America
Europe
Asia Pacific (APAC)
The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rapid Infuser Market Set for Steady Growth at 4.5% CAGR, Reaching US$1.64 Billion by 2033 | FMI Analysis

The Rapid Infuser Market is poised for a period of sustained expansion, fueled by the growing demand for efficient and precise fluid delivery in critical care settings. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the rapid infuser market is currently valued at US$1.056.3 million in 2023. Looking ahead, the market is expected to experience a steady Compound Annual Growth Rate (CAGR) of 4.5% over the next decade. This translates to a significant market expansion, with a projected valuation surpassing US$1.639.8 million by 2033.

Rapid infuser devices are indispensable components in emergency and intensive medical procedures, including anesthesia, labor and delivery, intensive care, trauma, and emergency surgery. These devices play a pivotal role in fluid infusion, a critical element in ensuring optimal patient care during crucial operations.

FMI’s comprehensive report sheds light on key business strategies that are instrumental in steering the rapid infuser market. Market leaders are strategically focusing on expanding their portfolios through rigorous product research and development initiatives. Additionally, strategic acquisitions are gaining momentum in the industry, indicating a proactive approach toward market dominance.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6716

Rapid Infuser Market Key Takeaways

Market revenues will surpass USD 817 million, with anesthesia and emergency healthcare applications being the primary driving factors
Hospitals will remain the leading end users, while ASCs are also likely to reflect steady growth on the back of growing adoption in outpatient medical procedures.
Trolley-mounted offerings continue to witness market preference, owing to portability and ease of use in hospital settings, accounting for ~70% of the market share.
North America followed by Europe, are leading regional market for rapid infusers, supported by massive investments into the healthcare sector, and easier access to new hospital and emergency care technologies.

“The global market for rapid infusers is driven by growing number of surgical procedures and high risk of hypothermia and hypovolemia. This product is also widely considered an important intervention in life-threatening ailments such as sepsis. These issues are major influencers in terms of market development through the forecast period,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Rapid Infuser Market– Who is Winning?

Smith’s Medical, GE Healthcare, BD, 3M Company, Stryker Corporation, ZOLL Medical Corporation, Belmont Instrument, Smisson-Cartledge Biomedical, Kewell Medical Technology Co. Ltd, Teleflex Incorporated, Biegler GmbHALC “TahatAksi”

impact the Global Rapid Infuser Industry. Demand largely remains stable as rapid infusers are standard equipment in most healthcare facilities for critical care applications. The demand for reusable rapid infusers is likely to fall in favor of single-use alternatives, owing to concerns over viral transmission.

Potential disruptions of raw material and component supplies due to lockdown and trade restrictions are concerns. However, the essential nature of the products, makes the industry largely exempt from government restrictions. Demand is unlikely to change substantially even in the post-pandemic period as applications in urology, gynecology, and ICUs continue unabated.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-6716

Key Segments Covered in Rapid Infuser Market Research

By Product:

Trolley Mounted Devices
Hand-Held Devices
Accessories

By Usability:

Single-Use Devices
Reusable Devices

By End-User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Laryngoscopes Market Booming at 5.4% CAGR, Reaching US$601.6 Million by 2033 | FMI Study

The Laryngoscopes Market is poised for robust growth, fueled by the increasing demand for these essential medical devices and continuous advancements in technology. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is on track to experience a steady Compound Annual Growth Rate (CAGR) of 5.4% from 2023 to 2033. This translates to significant market expansion, with the value expected to climb from US$355.1 million in 2023 to a staggering US$601.6 million by 2033.

This exceptional growth trajectory is fueled by a confluence of factors, including groundbreaking advancements in medical technology, an escalating prevalence of respiratory disorders, and a heightened emphasis on early diagnosis and treatment. At the heart of these developments, the laryngoscope market emerges as a crucial component in airway management and diagnostics, poised to play a pivotal role in elevating patient care and medical interventions.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12786

Key Takeaways from the Laryngoscopes Market Report

The Global Laryngoscopes Industry to exhibit surging sales as demand rises due to the increasing incidence of vocal or throat-related diseases
Increasing caution regarding hygiene has resulted in doctors adopting laryngoscopes to minimize invasion and contact
Reusable laryngoscopes are popular in the market due to their environmentally friendly properties
North America is expected to emerge as the leading market for laryngoscopes and is likely to remain dominant through the forecast period
While hospitals will continue exhibiting high demand, sales in specialty clinics as well are expected to surge in the coming years

COVID-19 Impact Analysis

Many industries have been affected by the COVID-19 pandemic, including the laryngoscope market. Production of laryngoscopes has decreased as a result of lockdowns and a travel ban. Despite the health sector’s demand for laryngoscopes, production has been slowed by a lack of resources and labor.

Following the pandemic, the market is anticipated to recover due to rising demand for non-invasive throat treatments. The pandemic’s increased focus on hygiene is also anticipated to increase demand for laryngoscopes. Starting in 2021, the market is anticipated to follow a positive trajectory.

Who Is Winning?

A small number of significant market players primarily control the Global Laryngoscopes Industry. Opportunities for the entry of new players in the market have been created by rising demand and advantageous governmental policies. Players are now looking to partner with various businesses to expand their growth.

The players’ attention has shifted to creating and innovating designs that improve comfort and safety. To correct flaws and errors in current laryngoscopes, important players are now involved in their development. As a result, there is now more competition among manufacturers to produce laryngoscopes that are better and more effective.

Johnson & Johnson, Pentax Medical Company, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Fujifilm Holdings Corporation, B. Brain Melsungen AG, Olympus Corporation, Medtronic Plc., Smith & Nephew PLC, Conmed Corporation, and Stryker Corporation are a few of the leading companies in the Global Laryngoscopes Industry.

Click Here To Get Your Full Report
https://www.futuremarketinsights.com/checkout/12786

Key Segments of Laryngoscopes Market Survey

Laryngoscopes Market by Product:

Rigid Laryngoscopes
Flexible Laryngoscopes
- Video Laryngoscopes
- Fiber Laryngoscopes

Laryngoscopes Market by End User:

Hospitals
Ambulatory Surgery Centers
Specialty Clinics

Laryngoscopes Market by Usability:

Reusable Laryngoscopes
Disposable Laryngoscopes

Laryngoscopes Market by Region:

North America Laryngoscopes Market
Latin America Laryngoscopes Market
Europe Laryngoscopes Market
East Asia Laryngoscopes Market
South Asia & Pacific Laryngoscopes Market
Middle East & Africa (MEA) Laryngoscopes Market

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Ophthalmic Tonometers Market Sees Clear Vision for Growth at 4.8% CAGR, Reaching US$507.9 Million by 2033 | FMI Study

The Ophthalmic Tonometers Market is sharpening its focus on the future, driven by the growing need for effective glaucoma management. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to experience a steady Compound Annual Growth Rate (CAGR) of 4.8% from 2023 to 2033. This translates to a significant expansion, with the market value expected to climb from US$317.7 million in 2023 to a projected US$507.9 million by 2033.

This robust growth trajectory is underpinned by several key factors, with a prominent focus on the rapidly expanding elderly population worldwide. As life expectancy rises and mortality rates decline, there is a synchronous increase in the prevalence of eye conditions associated with age. This demographic shift is a significant driver, leading to an anticipated surge in demand for ophthalmic tonometers.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12687

The food industries in the bulk of both developed and developing nations are thriving, which increases the population’s intake of unhealthy and sugar-filled foods and increases the risk of diabetes, heart disease, high cholesterol, and high blood pressure. Many eye issues could result from this, which is likely to have a direct effect on other body parts, particularly the eye. The need for tonometers to measure ocular pressure is pushed by these aspects.

During the forecast period, the market is also anticipated to be driven by growing patient awareness regarding early diagnosis and routine intraocular pressure (IOP) monitoring to prevent needless vision loss. Tonometer usage rates in hospitals and clinics are anticipated to increase with the implementation of favorable reimbursement policies.

The rising number of glaucoma screening programs planned by the commercial, semi-public, and public healthcare sectors is anticipated to fuel market expansion over the forecast period. The only method to identify glaucoma early is through routine eye exams because it has no apparent symptoms. The need for ophthalmic tonometers is increased by the rise in the number of eye examination clinics, which promotes awareness of glaucoma and its effects on vision.

The increased use of application tonometry in healthcare facilities also fuels market expansion. The test is widely used to determine intraocular pressure since it measures the force required to briefly flatten a piece of the cornea. Also, rebound tonometry’s advancement is promoting market expansion. Children and individuals with impairments can use rebound tonometry, which helps with measurements at various corneal sites.

During the forecast period, North America is anticipated to lead the market as a whole. The existence of important companies, the high rate of glaucoma in the region, and the advanced healthcare network all contribute to the market growth. Moreover, encouraging government efforts and a rise in research collaboration numbers are a few of the variables anticipated to fuel market expansion.

Ophthalmic Tonometers Market Key Takeaways

The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 5.0% through 2033.
The United States is expected to develop at a 5.6% CAGR during the forecast period.
With a CAGR of 3.9% over the forecast period, Canada is predicted to develop promptly in the market.
In China, the market is expected to proliferate, registering a CAGR of 7.2% over the forecast period.
Germany is estimated to grow decently registering a CAGR of 5.8% until 2033.

Ophthalmic Tonometers Market Competitive Landscape

Key players in the Global Ophthalmic Tonometers Industry are Nidek Co., Ltd, Eicemeyer Veterinary Equipment Ltd., Metall Zug, Huvitz, Topcon, Revenue Group Oyo, Kiowa Group, 66 VISION TECH Co., Ltd., Photon Surgical Systems Ltd., Jorgensen Laboratories, Nanjing Redsun Optical Co., Ltd., and AMETEK, Inc. and others.

These market players are actively involved in a dynamic environment marked by intense competition, technological advancements, and strategic alliances. They are leveraging unique strategies to bolster their market share and maintain their competitive edge. These firms are successfully carving out a strong market niche through astute product differentiation, robust marketing campaigns, and insightful product development. They are driving growth in this complex and multifaceted industry by generating fresh value propositions and meeting consumer demands by utilizing substantial research and development capabilities.

Ophthalmic Tonometers Market Recent Developments

The NT-530/510 Non-Contact Tonometer was unveiled by Nidek Co., Ltd. It has advanced APC (Auto Puff Control), noise reduction, 3-D auto tracking, auto shoot, and auto-completion functions.
With the HNT-7000 tonometer from Huvitz, tonometry has become simpler and more accurate. It has full auto-tracking monitoring and corneal thickness control.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-12687

Key Segments of Ophthalmic Tonometers Market Survey

By Product:

Human Applanation Tonometers
Human Indentation Tonometers
Human Rebound Tonometers
Veterinary Applanation Tonometers
Veterinary Rebound Tonometers

By Portability:

Handheld Tonometers
Desktop Tonometers

By End Use:

Hospitals
Ophthalmic Diagnostic Centers
Veterinary Hospitals
Veterinary Diagnostic Centers

By Region:

North America Ophthalmic Tonometers Market
Latin America Ophthalmic Tonometers Market
Europe Ophthalmic Tonometers Market
East Asia Ophthalmic Tonometers Market
South Asia & Pacific Ophthalmic Tonometers Market
Middle East & Africa (MEA) Ophthalmic Tonometers Market

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Forage Market Poised for 5.2% Annual Growth Through 2033, According to FMI

The worldwide sales of forage analysis, which was recorded to be worth US$ 651.6 million in 2018, but were estimated to have reached US$ 777.1 million by 2022. The annual growth rate was revised to 4.5% from 2018 to 2022 due to the altered business environment following the pandemic.

The net worth of the global forage market is figured out to be around US$ 817.5 million in the present year 2023. As per the recent market analysis report released by FMI, the market is projected to register a CAGR of 5.2% through 2033. Ultimately, the total valuation of the market is expected to reach US$ 1,357.3 million by the conclusion of this forecast period in 2033.

Request a Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-16671

Among the main factors boosting the global forage market throughout the forecast period is the rising global milk and milk product consumption. Additionally, there is a rise in the livestock population as a result of the region’s rising consumption of beef and meat products, further boosting the forage market.

Farmers’ increased awareness of farm animals’ nutritional needs is another key factor driving the global forage industry. The reduction of pasture or ranching space due to improper forest land management in the modern era is also increasing the product demand everywhere. Additionally, organic fodder is an emerging trend in the forage market, as it provides sufficient nutrients and farmers are favoring it more and more.

Key Takeaways from the Forage Market Study Report

The United States forage market is expected to be leading and be worth around US$ 223 million in the year 2023.
Meanwhile, the supply of forage feed from China is anticipated to register an 8.7% CAGR and overtake the United States in the future.
On the other hand, Latin American countries are expected to grow at an average growth rate of 5.5% during the forecast years. The demand for forage in agriculture-intensive countries like Brazil, Argentina, and Mexico is the key factor driving this geographical region market.
The nutrients forage market segment is anticipated to record a lucrative 6.6% CAGR and reach US$ 538.4 million by the year 2022.
While the market segment of Mycotoxins is reassessed to witness an average growth rate of 5.2% CAGR over the following ten years.
The dry matter forage segment is expected to witness an unexpectedly lower growth rate of 4.4% over the years from 2023 to 2033.

Competitive Landscape for the Forage Market Players

Allied Seed LLC, Cawood Scientific, CVAS Forage Lab, Dairy Land Laboratories, Dodson & Horrell, Eurofins Scientific, Intertek Testing Laboratories, Messy Feeds, Minnesota Valley Testing Laboratories, RJ Hill Laboratories, Servi-Tech Inc., SGS S.A., Barenbrug USA, BrettYoung Seeds Ltd., Cargill Incorporated, Corteva Inc., DLF Seeds A/S, Forage Genetics International LLC (Land O’Lakes Inc.), King’s Agriseeds Inc., Rivard’s Turf & Forage and Standlee Premium Products LLC among others are prominent players in the global forage market.

Recent Developments

The Cubeit Hay Company of Hamer became a business partner of the United States Team Penning Association or USTPA in April 2021. Several promotional and marketing campaigns may benefit from this association in the upcoming years, which can lead to higher business sales.
The Wilbur-Ellis Nutrition Company purchased Ametza LLC’s fodder pellet division back in the year 2021, during the pandemic. Ametza LLC, headquartered in California, produces and distributes fodder pellets to many leading American merchants serving the livestock animal industries.

Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/16671

Key Segments

By Crop Type:

Cereals
Legumes
Grasses
Others

By Target:

Nutrients
Mycotoxins
Dry Matter
Other Targets

By Forage Type:

Fresh Forage
Ration Forage
Hay Forage
Silage Forage
Dry Matter Forage
Other Forages

By Animal Type:

Forage for Cattle
Forage for Equine
Forage for Sheep
Forage for Poultry
Forage for Other Animals

By Region:

North America
Latin America
Europe
East Asia
South Asia and the Pacific
The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Packaged Currants Market Projected to Reach USD 1.2 Billion by 2033, Driven by a Consistent 4.8% Annual Growth

The Packaged Currants Market is witnessing steady growth as consumer awareness regarding the health benefits of these small yet potent berries continues to rise. Currants, rich in antioxidants, vitamins, and fiber, have gained popularity among health-conscious individuals seeking nutritious and versatile food options. Packaged currants, available in dried, frozen, and freeze-dried forms, cater to the convenience-seeking segment.

The global packaged currants market is expected to be worth US$ 979 million in 2023 and US$ 1.2 billion in 2033. Demand for packaged currants is expected to record a steady 4.8% CAGR, with the United Kingdom, the United States, China, and India becoming key producers.

Market Growth is expected to be Fueled by a rise in Online Shoppers

Market growth is expected to be sped up by the growing number of people who shop online. The product is used as a food supplement and for medical purposes, which is expected to drive market growth. It’s easy to find online, and buying it only takes a few steps. Also, the product can be used to replace fresh fruits. The product can improve cardiovascular health and lower the risk of stroke and high blood pressure. Such benefits are expected to speed up the market’s growth. It’s also used to treat skin problems like psoriasis, acne, and others. It helps treat obesity and arthritis. The growth of the packaged currants market is expected to be boosted by these factors in the coming years.

Request our Sample report and gain a competitive advantage in this flourishing industry! https://www.futuremarketinsights.com/reports/sample/rep-gb-16660

Higher Demand for Packaged Food Products

Market growth is expected to be boosted by the growing demand for packaged food products around the world. The product is widely used to help people lose weight and get other health benefits. It is used to relieve digestive problems like constipation. The product is also used to strengthen muscles and treat stress, depression, and anxiety. The product is widely used in jams, cakes, and other foods. Market growth is expected to be sped up by the high demand for treatments for diseases like chronic cough and others. The market is expected to grow because people are becoming more aware of how important it is to keep their collagen levels up and their spending power is growing. Also, the product is used to strengthen the immune system and lower the risk of cancer cells forming. The packaged currants market is expected to accelerate in the coming years due to these factors.

Key Takeaways

The trend of consumers seeking out organic and natural products has extended to packaged currants, leading to a rise in demand for organic and natural options in the market.
As busy lifestyles continue to dominate, consumers are increasingly seeking out on-the-go snacking options. This has led to an increase in demand for snack packs and portion control packaging, providing convenience and portion control.
Currants are gaining popularity as versatile ingredients, which has increased demand for packaged currants in various food and beverage applications, including baked goods, jams, jellies, and smoothies.
Companies are leveraging the power of technology and e-commerce channels to market and distribute their packaged currants, enabling them to reach new audiences and increase sales.
Currants are being used for their various health benefits, which has led to an increase in demand for packaged currants in traditional medical applications.
Companies are becoming more conscious of the impact their packaging has on the environment and are therefore investing in eco-friendly packaging materials, such as biodegradable and recyclable options, to meet this growing demand.

Competitive Landscape

The competitive landscape in the packaged currants market is characterized by huge established players and surging startups.

Established players in the market have strong brand recognition and a loyal customer base. They have well-established distribution networks, wide product portfolios, and significant financial resources. A few prominent players in the market include Ocean Spray Cranberries Inc., Suterra LLC, and Sun-Maid Growers of California.

Startups in the packaged currants market are entering the market with innovative products and business models. They are leveraging advances in technology and packaging to create new products and reach new customers. Startups are also focused on meeting the changing preferences of consumers, such as the demand for organic, natural, and functional packaged currants. Some of the startups in the market include Little Red Dot Kitchen, Berry Joe, and Rubies in the Rubble.

Ready to tap into the potential of the Packaged Currants Market? Get an edge over your competitors with comprehensive insights. Buy now and gain access to detailed segment information. https://www.futuremarketinsights.com/checkout/16660

Key Segments

Product:

Blackcurrant
Redcurrant

Application:

Online Sales
Offline Sales

Region:

North America
Latin America
Europe
Asia Pacific (APAC)
The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cell Culture Media Bags Market Set to Balloon at 10.5% CAGR, Reaching US$3.5 Billion by 2033 | FMI Study Report

The Cell Culture Media Bags Market is experiencing a significant upsurge, fueled by the flourishing biopharmaceutical research and production landscape. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is estimated to be valued at US$1,308.7 million in 2023. This figure is projected to reach a staggering US$3,541 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 10.5% over the next decade. This growth trajectory signifies the increasing importance of cell culture media bags in biopharmaceutical development and production.

At the forefront of the life sciences industry, the cell culture media bag market is currently experiencing a paradigm shift, driven by cutting-edge advancements in cell culture technologies. These innovations are shaping the landscape of the industry, with cell culture media bags playing a pivotal role in facilitating cell growth for a myriad of applications, ranging from pharmaceutical research to biotechnology.

Analysts attribute the surge in adoption of cell culture media bags to their unparalleled efficiency in providing a controlled environment for cell growth. These bags ensure optimal conditions for cell culture processes, offering advantages such as scalability, user-friendly features, and a reduced risk of contamination. This makes them indispensable in modern laboratory settings.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12670

Cell Culture Media Bags Market Key Takeaways

2D bag designs are expected to account for over half of the market value, owing to their high flexibility
Very large bags (>3000 ml) will remain the most sought out size, owing to low contamination properties
By host cell, the bacterial cell segment is projected to account for the majority of market value, ascribed to an increasing number of studies on diseases caused by bacteria.
Biopharmaceutical manufacturing will remain a key end-use segment, capturing over 2/3rds of market value through the forecast period.
The US will remain the largest market for cell culture media bags globally.

Cell Culture Media Bags Market Competitive Landscape:

In this fast-growing industry, partnerships and collaborations, product launches, expansions, and other strategies have been used to gain a major piece of the Global Cell Culture Media Bags Industry.

To meet the increased demand for bioprocess manufacturing activities, market participants are concentrating on up-scaling media bag production. In addition, producers are tackling problems and improving features of bags such as four-layered films that provide stronger oxygen and moisture barriers to the properties.

In this vein, Thermo Fisher Scientific released the CEDIA Mitragynine (Kratom) Assay, a novel immunoassay for kratom alkaloid mitragynine screening designed specifically for criminal justice and forensic purposes. Throughout the projection period, continuous product innovations will continue to define the competitive landscape of the market. Furthermore, industry participants are concentrating their efforts on producing products for specific end uses.

“Market players are investing in new product innovation and are focusing on procuring FDA approvals to facilitate wide-scale deployment,” remarks Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Who is Winning?

Cell culture media bag manufacturers are focusing on developing solutions that address the key challenges such as recycling multilayer flexible packaging consisting of plastic and barrier materials. Moreover, new product development and strategic partnerships have been identified as key growth strategies adopted by market players.

In April 2019, Thermo Fisher Scientific launched a new immunoassay – CEDIA Mitragynine (Kratom) Assay – for kratom alkaloid mitragynine screening solely for criminal justice and forensic applications.
In August 2015, Rim Bio partnered with Playmouth-based Sentrol for the sales and distribution of its single-use bio containers across the United States.

FMI’s report includes profiles of some of the most prominent names in the market including Parker Hannifin Corp, Pall Corporation, Sartorius AG, Thermo Fisher Scientific Inc., and GE Healthcare Inc.

List Of Key Players Covered in the Cell Culture Media Bags Market are:

Parker Hannifin Corp
Pall Corporation
Sartorius AG
Thermo Fisher Scientific Inc.
GE Healthcare Inc.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-12670

Key Segments:

Cell Culture Media Bags Market by Bag Size:

Very Small Bags (< 150 ml)
Small Bags (151 – 500 ml)
Medium Sized Bags (501 – 1000 ml)
Large Bags (1001- 3000 ml)
Very Large Bags (>3000 ml)

Cell Culture Media Bags Market by Application:

Storage
Mixing
Processing
Gas Exchanges
Heat Transfer
Turbidity
Flow Rate Monitoring
Pressure
Viscosity

Cell Culture Media Bags Market by Host Cell:

Mesenchymal Cells
Plant Cells
Insect Cells
Bacteria Cells
Yeast Cells
Chinese Hamster Ovary
Baby Hamster Kidney

Cell Culture Media Bags Market by Bag Design:

2D Cell Culture Media Bags
3D Cell Culture Media Bags

Cell Culture Media Bags Market by End Use:

Life Science R&D
Biopharmaceutical Manufacturers

Cell Culture Media Bags Market by Region:

North America Cell Culture Media Bags Market
Latin America Cell Culture Media Bags Market
Europe Cell Culture Media Bags Market
East Asia Cell Culture Media Bags Market
South Asia & Pacific Cell Culture Media Bags Market
Middle East & Africa (MEA) Cell Culture Media Bags Market

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Dermatology Lasers Market Set to Beam Bright with 7.0% CAGR, Reaching US$3.49 Billion by 2033 | FMI Analysis

The Dermatology Lasers Market is poised to experience a radiant future, fueled by the growing demand for minimally invasive aesthetic procedures and advanced medical treatments. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to witness a stellar Compound Annual Growth Rate (CAGR) of 7.0% over the next decade (2023-2033). This translates to a projected market valuation of US$3.49 billion by 2033, reflecting a significant rise from the US$1.77 billion valuation in 2023.

This comprehensive forecast sheds light on the industry’s robust momentum, attributing the surge to key factors such as technological advancements, a heightened aesthetic consciousness among consumers, and an expanding patient pool actively seeking cutting-edge skincare solutions.

The Prevalence of Skin Problems is Increasing

Skin disorders and cosmetic issues are accurately targeted and treated with specialized lasers in laser dermatology. The availability of beauty and dermatological laser treatments, rising population spending power, the increased popularity of cosmetic surgery, and the presence of top dermatology laser machine providers are the important factors expected to shape the dermatology laser sector.

The high prevalence of skin cancer is anticipated to impact laser treatment adoption, resulting in increased dermatology laser sales. Furthermore, medical device research and development talents are becoming more prevalent as new healthcare technologies are implemented.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12662

The growing elderly population and increasing healthcare infrastructure development expenditures in developing economies are two main factors bolstering the growth of the dermatological lasers market. The industry is experiencing tremendous growth as a result of increased demand in the beauty and personal care sectors, however, some factors are limiting its growth.

The high cost of laser treatment, skin discoloration in some situations, the danger of skin infection, and the heat released by the laser that might permanently damage the retina of the eye are factors affecting the market growth.

Hair removal and face rejuvenation are expected to remain the most popular dermatology laser application areas, owing to increased consumer spending on appearance maintenance.

Skin lasers are medical devices that use concentrated beams of light to treat a variety of skin conditions. These lasers are commonly used in dermatology practices and can be classified into several categories based on the wavelength of the light they emit.

Key Points from the Dermatology Lasers Market:

The market is expected to surpass US$ 3,487.8 billion by 2033.
Important factors driving market expansion include increased incidences of skin disorders such as psoriasis and vitiligo around the world, which are expected to propel the worldwide market.
The dermatology lasers market is expected to secure a CAGR of 7.0% during the forecast period 2023 to 2033.
North America dominated the dermatology lasers market.

Key Developments in the Dermatology Lasers Market

January 2020 – Nurnberg, Germany, announced the release of the groundbreaking applicator ClearSkin PRO. This product has twice the strength of previous remedies, resulting in skin that seems to be younger.
July 2018 – Candela Corporation reported that its Vbeam Prima, an advanced 595 nm pulsed dye laser, had received FDA approval (PDL). This product includes a new 1,064 nm wavelength as well as other innovative features that can successfully treat a wide range of skin diseases.
February 2021 – POETYK PSO-2, the second pivotal Phase III clinical trial investigating deucravacitinib, a new, selective tyrosine kinase 2 inhibitor for the treatment of patients with moderate to severe plaque psoriasis, was announced by Bristol Myers Squibb Company. POETYK PSO-2 compared deucravacitinib 6 mg once daily to placebo and met both co-primary objectives, with significantly more patients reaching Psoriasis Area and Severity Index (PASI 75).
May 2020 – Dupixent (dupilumab) was approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis.
April 2020 – JUBLIA (efinaconazole) topical solution for the treatment of onychomycosis was approved by the United States Food and Drug Administration (FDA) for Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics.

Click Here To Get Your Full Report
https://www.futuremarketinsights.com/checkout/12662

Key Companies Profiled in the Dermatology Lasers Market:

Cutera, Inc.
Cynosure, Inc.
Alma Laser
En.
Candela Medical

Dermatology Lasers Market Key Segmentation

By Product:

Solid-state Lasers
- Diode Lasers
- Nd:YAG Lasers
- Er:YAG Lasers
Gas Lasers
- CO2 Lasers
- Excimers Lasers
Pulsed Dye Lasers

By Technology:

Ablative Lasers
Non-ablative Lasers

By Application:

Hair Removal
Facial Rejuvenation
Tattoo Removal
Scar Treatment
Skin Cancer
Psoriasis
Vitiligo
Varicose Veins
Actinic Keratosis
Wound Treatment
Others

By End User:

Hospitals
Ambulatory Surgical Centres
Dermatology & Cosmetic Clinics

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

PD-1/PD-L1 Inhibitors Market Booming at 9.6% CAGR, Poised to Reach US$123.3 Billion by 2033 | FMI Study

The PD-1/PD-L1 Inhibitors Market is experiencing a revolutionary transformation, fueled by their groundbreaking impact on cancer treatment. A recent market analysis forecasts a phenomenal Compound Annual Growth Rate (CAGR) of 9.6% from 2023 to 2033. This translates to a substantial increase, with the market value expected to skyrocket from US$49.5 billion in 2023 to a staggering US$123.3 billion by 2033. This press release highlights the significant growth potential within the PD-1/PD-L1 inhibitors industry.

The driving force behind this monumental growth is the escalating global burden of cancer. PD-1 and PD-L1 inhibitors heralded as pivotal immune checkpoint inhibitors, spearhead the battle against cancer by serving as indispensable frontline treatments across a diverse spectrum of cancers. Their burgeoning demand underscores their irreplaceable role in the ongoing fight against this relentless disease.

One standout player in this dynamic market is Pembrolizumab, better known as KEYTRUDA. This immunotherapy drug has garnered global acclaim for its proven efficacy in treating a wide array of FDA-approved disorders. KEYTRUDA has become a beacon of hope for patients and a trusted choice for healthcare professionals worldwide.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12644

The increased R&D activities are projected to generate considerable growth potential for key competitors in the Global PD-1/PD-L1 Inhibitors Industry. Market participants, for example, are expanding their spending in research and development to fulfil increased demand.

Anti-PD-1 and anti-PD-L1 immunotherapies for patients with metastatic melanomas are being developed by researchers at Johns Hopkins Kimmel Cancer Centre. The therapy’s purpose is not to directly destroy cancer cells, but to disrupt a route that protects tumour cells from immune system components capable of fighting cancer.

PD-1/PD-L1 Inhibitors Market Key Takeaways

The hospital pharmacies category is predicted to have a considerable market share of 48.3% over the projection period because of its vast client base, rising healthcare expenses, and rising cases of diseases such as lung and bladder cancer, melanoma, Hodgkin lymphoma, and others.
By 2033, the United States is expected to generate US$ 23.4 billion in revenue. The government is increasing funding and support for cancer drug development. A boom in market research and development for new and innovative pharmaceuticals is also supporting regional growth.
China is expected to be a lucrative market, with a 14.0% annual growth rate. The sale of approved therapies and the increasing occurrence of blood-related tumours are two of the key causes for the significant rise of the PD-1 and PD-L1 inhibitors market. Vendors’ rising patient support programmes are moving the market in this region ahead.
Pembrolizumab is expected to grow at an 8.7% annual pace throughout the forecast period, reaching a significant market share of 49.5% in 2022. Pembrolizumab’s use has expanded due to its established efficacy in treating FDA-approved indications such as head and neck squamous cell cancer (HNSCC), non-small cell lung cancer (NSCLC), melanoma, and others.
Tamil Nadu in India is developing a treatment policy to identify 66.0% of cancer patients in the first and second stages by 2030, allowing for proper treatment. As a result, such a policy is expected to fuel demand for PD-1 inhibitor drugs, propelling the growth of the segment over the forecast period.

Manufacturers are Constantly Evolving Business Models

Companies in the Global PD-1/PD-L1 Inhibitors Industry are moderately competitive by nature, with several key players present. These players are part of several strategic alliances. The agreement and system automation speed up the manufacturer’s strategy to capitalize on market share and capture a sizable market share.

PD-1/PD-L1 Inhibitors Market Key Players:

Akeso Inc.
Alphamab Oncology
Amgen Inc.
AstraZeneca Plc
BeiGene Ltd.
Bristol Myers Squibb Co.
Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
Eli Lilly and Co.
Others

Latest Developments in the PD-1/PD-L1 Inhibitors Market

Novartis International AG acquired The Medicines Company in January 2020. This acquisition aided Novartis in using a vaccine-like approach to treat the world’s leading cause of mortality and disability.
Merck announced the FDA approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy, with or without bevacizumab, in October 2021. Patients with persistent, recurrent, or metastatic cervical cancer whose tumours express PD-L1 (Combined Positive Score [CPS] 1) as determined by an FDA-approved test are given the therapy.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-12644

PD-1/PD-L1 Inhibitors Market Segment by Category

By Product:

Nivolumab
Pembrolizumab
Atezolizumab
Avelumab
Durvalumab

By Indication:

Melanoma
Non-Small Cell Lung Cancer (NSCLC)
Renal Cell Carcinoma (RCC)
Head and Neck Squamous Cell Cancer (HNSCC)
Bladder Cancer
Merkel Cell Carcinoma (MCC)
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us: